New research shows that certain genetic markers could dictate how prone people are to cannabis addiction.
A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.
Cannabis' famed pacifying properties could make it an excellent candidate for future pharmaceuticals to treat PTSD.
A significant minority of major depressive disorder patients don’t respond to currently available antidepressant medication. A newly approved treatment, based on the "club drug" ketamine, could change that. In a session at the British Neuroscience Association’s Festival of Neuroscience 2019, the potential mechanisms of ketamine’s antidepressant action were put under examination.
Research shows how cannabidiol can bring vital medication through the brain's blood barrier to its treatment area.
Medical records show that patients who regularly consumed cannabis were put under stronger sedation before undergoing routine procedures.
Marijuana's taking the leap from campus contraband to syllabus subject. But what can students expect to learn?
The scientific researchers of cannabis could be studying a plant far less potent than the one many readily consume.
The new study suggests using the two drugs together could reduce risk of dependency without causing cognitive problems.